The latest closing stock price for VTv Therapeutics as of September 18, 2024 is 14.03.
An investor who bought $1,000 worth of VTv Therapeutics stock at the IPO in 2015 would have $-968 today, roughly -1 times their original investment - a -31.73% compound annual growth rate over 9 years.
The all-time high VTv Therapeutics stock closing price was 435.60 on July 30, 2015.
The VTv Therapeutics 52-week high stock price is 30.99, which is 120.9% above the current share price.
The VTv Therapeutics 52-week low stock price is 7.38, which is 47.4% below the current share price.
The average VTv Therapeutics stock price for the last 52 weeks is 16.94.
An investor who bought $1,000 worth of VTv Therapeutics stock at the IPO in 2015 would have $-968 today, roughly -1 times their original investment - a -31.73% compound annual growth rate over 9 years.
The all-time high VTv Therapeutics stock closing price was 435.60 on July 30, 2015.
The VTv Therapeutics 52-week high stock price is 30.99, which is 120.9% above the current share price.
The VTv Therapeutics 52-week low stock price is 7.38, which is 47.4% below the current share price.
The average VTv Therapeutics stock price for the last 52 weeks is 16.94.